LYN and chronic myelogenous leukemia, BCR-ABL1 positive: At present, the precise molecular mechanisms responsible for increased Lyn expression and activation in CML have not been established, although it is likely to involve induction and/or re-wiring of other signalling pathways linked to haematopoietic cell function.